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CObjective: Patient reporting of symptoms in a questionnaire with a
7-day recall period was expected to differ from symptom reporting in a
7-day symptom diary on the basis of cognitive theory of memory pro-
cesses and several studies of symptoms and health behaviors.
Methods: A total of 101 adults with chronic obstructive pulmonary
disease (COPD) completed a daily diary of items measuring symptoms
and impacts of COPD for 7 days, and on the seventh day they completed
a questionnaire of the same items with a 7-day recall period. The anal-
ysis examined concordance of 7-day recall with summary descriptors
of the daily responses, examined the magnitude and covariates (pa-
tient characteristics and response patterns) of the difference between
7-day recall and mean of daily responses, and compared the discrimi-
nant ability and ability to detect change of 7-day recall and mean of O
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doi:10.1016/j.jval.2011.12.005aily responses. Results: A 7-day recall was moderately concordant
ith the mean and maximum of daily responses and was 0.34 to 0.50
Ds higher than the mean of daily responses. Only the weekly report
tself was a covariate of the difference. The discriminant ability and
bility to detect change were equivalent. Conclusions: In measuring
he weeklong experience of COPD symptoms and impacts on groups of
atients, the 7-day recall scores were higher than the daily diary scores,
ut equivalent in detecting change over time.
eywords: COPD, mental recall, questionnaires, signs and symptoms,
alidation studies.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Dyspnea is one of the most common and disabling symptoms for
patients with chronic obstructive pulmonary disease (COPD) [1].
The American Thoracic Society’s consensus statement on dys-
pnea describes dyspnea as “a subjective experience of breathing
discomfort that consists of qualitatively distinctive sensations
that vary in intensity” [2]. Patients with COPD frequently report
reductions in daily functional status and overall quality of life
because of limitations in their activities due to respiratory discom-
fort. Assessment of the patient experience is especially important
in COPD, because there is known discrepancy between the sever-
ity of COPD and dyspnea per clinical assessment and the severity
of dyspnea and its impacts experienced by patients [2,3].
The Food and Drug Administration Patient-Reported Outcome
PRO) Guidance describes the standardized process of developing
RO instruments for clinical trials. One step is selecting and pro-
iding justification for the recall period [4]. A model of recall peri-
ds in PRO instruments illustrates that the optimal recall period
epends in part on the characteristics of the event being mea-
ured, such as the frequency of occurrence and the rate of fluctu-
tion [5]. The goal of this analysis was to compare daily diary and
eekly reporting to determine whether they provide similar infor-
ation about the weeklong symptom experience of patients with
OPD.
* Address correspondence to: Antonia V. Bennett, Department of E
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1098-3015/$36.00 – see front matter Copyright © 2012, Internation
Published by Elsevier Inc.The accuracy of short-term retrospective recall (1–4 weeks) in
measuring daily experience has been tested in several areas: uri-
nary and fecal incontinence [6–9], symptoms and impacts of type
2 diabetes [10], symptoms of cystic fibrosis [11], physical activity
12,13], and alcohol consumption [14,15]. Correlation between
aily diary and retrospective reporting varied widely across stud-
es, ranging from 0.33 to 0.89. Furthermore, within some studies
he correlation varied by level of bother or severity and by patient
haracteristics. A study of urinary incontinence found that the
orrelation was higher for patients who were moderately or
reatly bothered by urge incontinence than for those who were
lightly or not bothered by it (0.812 vs. 0.528) [7]. In a study of
hysical activity, the correlation was higher for very hard physical
ctivity than for less intense physical activity, and correlations
ere higher for men than for women [12]. Most studies of recall
eriods report only correlation coefficients, but not the slope of the
elationship between each type of measurement or the difference
n mean scores. A study of cystic fibrosis symptoms found that the
oncordance of 7-day recall and mean of daily diary responses was
igh (range: 0.72–0.85; concordance is described in the “Methods”
ection) and the average difference was less than one-quarter of a
esponse scale point [11]. A study of symptoms and impacts of
ype 2 diabetes found moderate to high concordance of 7-day re-
all and mean of daily diary responses (range: 0.65–0.86) and the
verage difference ranged from 0.22 to 0.77 on an 11-point scale;
miology and Biostatistics, Memorial Sloan-Kettering Cancer Cen-
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
467V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 4 6 6 – 4 7 4for some items, the amount of difference was positively associated
with the variation in daily reports [10].
Retrospective recall has also been compared with ecological mo-
mentary reporting, that is, repeated real-time reporting by subjects
during their day-to-day life. These studies found that 1) recalled
pain is most similar to the maximum and last reports, 2) patients
with greater variability in real-time reports of pain will recall a
higher level of pain than the average of their real-time reports, and
3) while the group-level correspondence between real-time re-
ports and recall is moderate, the within-person correspondence is
low [16–18].
This study is the first to compare recall periods for measuring
symptoms of COPD. It is not known whether the similarities in
retrospective and daily reporting found previously in respiratory
symptoms (e.g., cystic fibrosis [11]) are consistent across respira-
tory symptoms of other diseases. This study will also provide ad-
ditional data on the variation of the difference in 7-day recall and
the mean of daily diary responses by patient characteristics,
symptom severity, and daily variation in symptoms.
The analysis was organized in four parts: 1) comparison of the
weekly item response with summary descriptors of daily diary
item responses; 2) examination of the difference between the
weekly response and mean of daily diary responses for subgroups
defined by patient characteristics and by patterns of diary re-
sponses; 3) comparison of the ability of the weekly response and
the mean of daily responses to discriminate between known
groups defined by patient health status; and 4) comparison of the
ability of the weekly response and the mean of daily responses to
detect change over time. Two hypotheses based on cognitive the-
ory and studies of recall were tested. In Part 1 of the analysis, it was
expected that the weekly response would be most similar to the
maximum daily report and the last daily response (day 7). In Part 2
of the analysis, it was expected that the difference between the
weekly response and mean of daily responses would be larger in
diaries with greater variability in daily responses.
Methods
This study is a secondary analysis of PRO data originally collected
for the development and validation of a COPD symptom diary,
which has provided a rare opportunity to compare daily diary re-
Table 1 – Daily and weekly items from the DPD, listed by c
Severity of breathing problems
Daily item Rate the overa
this mornin
Weekly item Rate the overa
Response options for both items Not at all seve
severe/extr
Activity limitation due to breathing problems
Daily item How much ha
to do today
Weekly item Overall, how m
wanted to d
Response options for both items Not at all/a lit
Feeling upset during breathing problems
Daily item How often did
Weekly item How often did
Response options for both items None of the ti
bit of the tim
Note: Each set of response options is scored from 0 to 6, where not a
DPD, Dyspnea Patient Diary.porting with 7-day recall.Diary
The Dyspnea Patient Diary (DPD) assesses “relief from dyspnea”
and the degree to which this relief impacts patients with COPD. It
includes symptom and impact questions relevant to COPD that
measure the pattern, severity, and intensity of symptoms and
symptom-related impacts. The DPD is presented as an electronic
handheld device (similar to a PalmPilot) with one question per
screen. It is completed by patients twice each day, once in the
morning just after their morning routine and before the “start” of
their day, and once in the evening before going to bed. Scoring of a
daily item in the DPD requires the daily item to be completed by
the patient at least 5 out of 7 days.
The DPD was developed by integrating information from pa-
tients, the literature, and key clinical and methodological experts.
The DPD was found to have sound cross-sectional validity (unpub-
lished report) [19]. Change in DPD scores due to treatment remains
to be evaluated in a clinical trial with a sample size larger than that
in the preliminary validation study.
The DPD items included in this analysis are listed in Table 1;
the three constructs measured by the items are overall severity of
breathing problems, activity limitations due to breathing problems, and
feeling upset during breathing problems. These three constructs were
measured by the DPD by using a daily item administered in the
evening that asks about that day’s experience and a weekly item
with a 7-day recall period that is completed on the last day (day 7)
of the diary period.
The DPD assessed the daytime but not the nighttime severity of
these three constructs in the daily diary. Data on the occurrence of
distinct breathing problems (e.g., inability to breathe; difficult,
heavy breathing; and trouble breathing deeply) measured in the
morning and evening diaries indicate an equal or slightly higher,
but no statistically significant difference in the rate of breathing
problems in the daytime compared with the nighttime [19]. We
expect that the daytime and nighttime severities of symptoms are
the same to the point that the daytime report is representative of
the daytime and nighttime average.
Data collection
Data were collected in an observational study of 101 patients with
COPD beginning a new treatment as part of a natural progression
in their medical care. Research participants were recruited
through medical clinics in the United States at the point when
ruct.
erity of your breathing problems since you completed the diary
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severe
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468 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 4 6 6 – 4 7 4necessitated a change in therapy. Eligible patients were male or
female, ages ranging from 40 to 80 years, diagnosed with COPD
characterized by airflow limitation that is not fully reversible, met
the spirometry criteria for moderate to very severe stage of disease
(forced expiratory volume in the first second of expiration [FEV1]/
forced vital capacity 70% and FEV1 80% predicted) [20], current
r ex-smokers with a smoking history of 10 or more pack-years,
nd had self-reported breathing difficulty (Medical Research
ouncil [MRC] grade 1; the MRC scale is described below). Pa-
ients were excluded if they used oxygen therapy at rest as well as
uring daily activities (this did not include those who used it solely
uring sleep or those who used it for exertion); if they had experi-
nced three or more COPD exacerbations that required inpatient
ospitalization in the past 12 months; if they had active cardiovas-
ular comorbidity within the past 6 months that was unstable
nd/or contributed significantly to their dyspnea; if they had self-
eported or a physician diagnosis of concurrent asthma or respi-
atory allergies; if they had a history of lung cancer, lung resection,
ung volume reduction surgery, or pulmonary fibrosis; and if they
ad an admitted significant history of alcohol or drug abuse within
he past year. The partial list of inclusion and exclusion criteria
isted above is intended to describe the health status of the study
ample in this analysis; a complete list is available on request.
Patients were then assigned to either cohort R, a pulmonary
ehabilitation program lasting 6 to 8 weeks, or cohort M, in which
atients received a pharmacological maintenance medication for
OPD, depending on the patient’s needs.
Figure 1 shows the measurement schedule for each cohort.
ohort R patients completed the DPD for 7 days before the start of
heir pulmonary rehabilitation program, and then they resumed
se of the DPD for 7 additional days beginning the day after the
nd of the rehabilitation program. On the last day of each 7-day
iary period, cohort R patients completed the DPD items about
heir symptom experience over the past 7 days. This provided a
aximum of 2 weeks of diary data for analysis for patients in
ohort R. Cohort M patients completed the DPD every day over the
ourse of 4 weeks. The change in their medication began on the
econd day of diary completion. The majority of cohort M pa-
Cohort R Enrollment Week 1
654321
DPD Diary XXXXXX
DPD 7-day 
Recall 
etucA2v63-FS
XscihpargomeD
Spirometry X
Cohort M Enrollment Week 1
 1 2 3 4 5 6
DPD Diary  X X X X X X
DPD 7-day 
Recall 
XetucA2v63-FS
XscihpargomeD
Spirometry X
Fig. 1 – Scheduients returned the DPD PalmPilot at their follow-up clinic visithat occurred, as possible, near the end of week 4. Therefore,
nly a maximum of 3 weeks of diary data were analyzed for
ohort M patients.
The short-form 36 health survey version 2 (SF-36v2) Acute ver-
ion was completed by cohort R at the end of weeks 1 and 2 and by
ohort M at baseline. The SF-36 Acute version, US version 2.0, is a
6-item measure of general health status. The acute version of the
F-36 has a recall period of the past 7 days instead of the past 4
eeks. The Physical Functioning and Mental Health subscale
cores were included in this analysis, and are scored on a scale of
to 100, in which the US average is 50 and higher scores indicate
etter health [21,22].
Patient demographic information, including age, gender, eth-
icity, and educational level, and disease-specific health informa-
ion, including years since diagnosis, smoking history, lung func-
ion, and MRC grade, were collected at enrollment. Lung function
as measured via spirometry test and reported as FEV1%. FEV1%
indicates forced expiratory volume in the first second as a percent
of the volume predicted for a person with healthy lung function of
the same age, height, and sex. Patients with FEV1 between 30% and
50% predicted are limited in daily activity by shortness of breath,
and patients with FEV1 of less than 30% have severe functional
impairment [23]. The MRC scale is a single-item measure in which
patients report the amount of activity that produces dyspnea; the
response options are 0  “strenuous exertion,” 1  “hurrying on
level ground,” 2  “stop after a mile or so,” 3  “stop after 100
yards,” and 4  “can’t leave the house” [2,24].
Human subjects research
Institutional review board approval was granted for the collection
of data and additionally for the secondary use of de-identified data
in this analysis; data collection and analysis were conducted in
accordance with ethical standards described in the 1964 Declara-
tion of Helsinki.
Statistical analyses
Analyses were limited to observations with both the weekly
Pulmonary 
Rehabilitation 
Program (6-8 weeks) 
Week 3
7654321
XXXXXXX
X
X
Week 2 Week 3
1 2 3 4 5 6 7 1 2 3 4 5 6 7
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469V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 4 6 6 – 4 7 4the three constructs was analyzed separately, because con-
structs that are emotionally charged, such as feeling upset during
breathing problems, may be recalled differently. Statistical signif-
icance was defined as P  0.05 with two-sided 95% confidence
intervals, and standard errors were estimated by using the clus-
tered sandwich estimator to account for correlation from mul-
tiple diaries per patient.
1. Comparison of the weekly response with descriptors of the
daily diary responses
For each construct, the weekly response was compared with de-
scriptors of the daily diary responses (e.g., mean, median, and
maximum of daily responses) to identify what the weekly re-
sponse most closely approximated. A list of each descriptor is
shown in Table 2. The weekly response was compared with each
descriptor of the daily diary response by the difference in group
means and by a measure of concordance. The difference in group
means was evaluated on the basis of whether it was less than a
small effect size of 0.20 SDs [25]. This effect size was calculated by
ividing the difference by the average of the two SDs (SD mean
aily diary and SD weekly response), because there was no reason
o choose one over the other. Concordance was measured by the
oncordance correlation coefficient (CCC), which is composed of
earson’s correlation coefficient and a bias correction factor. The
ias correction factor ranges from 0 to 1, where values closer to 1
ndicate less deviation of the Pearson’s best-fit line from the 45°
rigin line (the concordance line) [26,27]. The CCC ranges from 1
o 1, and values closer to 1 indicate greater concordance. The
CC was interpreted per the threshold of agreement recom-
ended for the intraclass correlation coefficient, in which 0.70 or
reater indicates a high level of agreement, because the statistics
re algebraically similar and consistent with each other [26]. The
ntraclass correlation coefficient has the disadvantage that it can-
ot be decomposed into a correlation coefficient and bias factor.
2. Examine the difference between the weekly response and the
mean of daily diary responses for subgroups defined by patient
characteristics and patterns of diary responses
The amount of difference between the weekly response and mean
daily responses was compared by subgroups of patient character-
istics and response patterns to identify characteristics of the data
in which the results of daily diary and weekly measurement may
differ. The patient characteristics and subgroups were gender, age
(49–64 years, 65 years), education (beyond high school and not
eyond high school), tertiles of SF-36v2 Acute Physical Function-
Table 2 – Descriptors of the daily diary item responses.
Descriptor What it measures
Mean Average of daily reports
Median Median of daily reports
Mode—max Most common response (largest
mode if multiple modes)
Mode—min Most common response (smallest
mode if multiple modes)
Maximum Most severe response
Minimum Least severe response
Day 7 (last day) Response of the same day the
weekly report was completed
Day 6 Response of the day before the
weekly report was completed
Day 1 (first day) First daily report
Note: The weekly report comprises items with 7-day recall com-
pleted on day 7 of the weeklong diary period.ng and Mental Health subscale scores, MRC grade (grades 0–1, 2,and 3–4), and years since diagnosis with COPD (2 years and 2
years). The response patterns were the range of daily responses
(maximum minus minimum daily response), the SD of daily re-
sponses, the mean of daily responses, and the weekly response.
For each characteristic, to evaluate variation in the amount of
difference by subgroup (or by units of continuous variables), linear
regression was used to test for a trend where the null hypothesis
was that the slope of the trend line is zero. The analyses in Parts 2,
3, and 4 of this study compare weekly response with the mean of
daily responses because diaries measuring symptom severity are
typically scored on the basis of the mean of daily reports.
3. Comparison of the ability of the weekly response and the
mean of daily diary responses to detect differences between
known groups
The ability of the mean of daily diary responses and the weekly
response to detect differences between known groups (i.e., dis-
criminant ability) was compared by calculating t statistics via lin-
ear regression for the differences in item scores by sample sub-
groups and comparing the t statistics between each type of
measurement. The subgroups were defined by tertiles of SF-36
Physical Functioning subscale scores, tertiles of SF-36 Mental
Health subscale scores, and MRC grade (0 –1, 2, and 3– 4). The
null hypothesis of the t statistic was that there was no differ-
ence between sample subgroups. The discriminant ability was
not tested by using subgroups of FEV1% because spirometry val-
es are known to be weak predictors of functional status and
uality of life [28].
4. Comparison of the ability of the weekly response and the
mean of daily diary responses to detect change over time
The average change in scores from time 1 to time 2 was compared
between the weekly questionnaire and the daily diary. Diaries at
time 1 were the first diaries (week 1) of both cohort R and cohort M.
Diaries at time 2 were the last diaries for each cohort (week 2 for
cohort R and week 3 for cohort M). For each type of measurement,
a t statistic was calculated for the difference in mean scores be-
ween time 1 and time 2, where the null hypothesis was that the
ifference is zero. The effect size of the change from time 1 to time
, calculated as Cohen’s d and using pooled SD, was also deter-
ined [25,29].
Results
Patient characteristics
Eight clinic sites located in the United States recruited and en-
rolled a total of 101 patients in the study. Diary data from 98 (97%)
patients were used in this analysis; 3 patients did not have suffi-
cient daily or weekly data to have at least 1 week of diary data
included in the analysis. Of the 98 patients, 73 (74%) were enrolled
through sites in California, 17 (17%) through sites in Pennsylvania
and Michigan, and 8 (8%) through sites in Georgia and Alabama.
Patient demographic characteristics are shown in Table 3. Fifty-
two (53%) patients were females, and 94 (96%) patients were white.
The mean (SD) age of patients was 65.2 (7.7) years, and the mean
(SD) years of education was 13.3 (2.4). Forty-eight (49%) patients
were educated beyond high school. Thirty-nine (40%) patients
were enrolled in cohort R, and 59 (60%) patients were enrolled in
cohort M. Demographic characteristics did not differ by cohort.
Patient clinical and self-reported health
The mean (SD) time since diagnosis with COPD was 4.8 (5.6) years
(Table 3). Patients had a smoking history measured by mean (SD)
pack-years of 53.8 (29.3). Cohort R had more limited lung function
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470 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 4 6 6 – 4 7 4(%FEV1) than did cohort M (41.5 [15.5] vs. 49.7 [15.0]; P  0.01). The
imitations due to breathing problems, measured by the MRC
cale, were greater for cohort R than for cohort M (2.9 [0.9] vs. 1.9
0.9]; P 0.001). Patient’s self-rated health was low; 16% rated their
health as “excellent” or “very good,” 39% as “good,” and 45% as
“fair” or “poor.” Patient’s physical and mental health, as measured
by the SF-36v2 Acute version, was lower than the US average;
Table 3 – Patients’ demographic characteristics.
All patients, n (%)
98 (100)
Females 52 (53)
Age (y), mean (SD)* 65.2 (7.7)
49–64 50 (51)
65 48 (49)
White 94 (96)
Nonwhite† 4 (4)
Years of education, mean (SD)‡ 13.3 (2.4)
Beyond HS 48 (49)
Not beyond HS 50 (51)
Years since COPD diagnosis 4.8 (5.6)
Number of pack-years§ 53.8 (29.3)
FEV1 (%) 46.4 (15.6)

MRC score 2.3 (1.0)
0  “Strenuous exertion” 0%
1  “Hurrying on level ground” 25%
2  “Stop after a mile or so” 36%
3  “Stop after 100 yards” 26%
4  “Can’t leave house” 13%
Self-rated health 3.4 (0.9)
1  Excellent 1%
2  Very Good 15%
3  Good 39%
4  Fair 32%
5  Poor 13%
SF-36v2 Acute¶
Physical functioning 30.8 (9.4)
Role-physical 34.0 (10.6)
Bodily pain 44.4 (11.0)
General health 38.4 (10.5)
Vitality 41.5 (10.3)
Social functioning 40.4 (12.7)
Role-emotional 40.4 (13.7)
Mental health 45.7 (11.5)
Physical component score 34.2 (9.6)
Mental component score 46.3 (12.7)
COPD, chronic obstructive pulmonary disease; FEV1, forced expira-
tory volume in the first second of expiration; HS, high school; MRC,
Medical Research Council; SF-36v2, Short-Form 36 Health Survey,
version 2.
* Patients were eligible if between 40 and 80 y old.
† Four patients (4%) were nonwhite; one was black/African Ameri-
can, one was Asian/Pacific Islander, and two were Hispanic/La-
tino.
‡ Years of education is the highest grade of school completed (e.g.,
12  high school graduate, 16  graduate of 4-y college).
§ One pack-year is equal to smoking one pack (20 cigarettes) per
day for 1 y. One patient in the medicine cohort did not have this
information—the t test is based on df  95.
 Difference between cohort R and cohort M is significant at P 
0.05; values are reported in text.
¶ SF-36v2 Acute version data reported are from the first assess-
ment of each cohort.patients had a mean (SD) Physical Functioning subscale score of30.8 (9.4) and a mean (SD) Mental Health subscale score of 45.7
(11.5). The SF-36v2 Acute Physical Functioning subscale scores
were lower for cohort R than for cohort M (32.3 [23.2] vs. 41.4 [21.1];
P  0.049).
Diary characteristics
Patients completed, at least partially, 252 weeks of dairy data.
Eighteen (7%) of these weekly diaries were missing the weekly
report and were therefore excluded from analysis. An additional
eight (3%) diaries had fewer than five daily reports and were also
excluded from analysis. Of the remaining 226 diaries, 161 (71%)
had five daily reports and 65 (29%) had five or six daily reports. The
missing days were equally distributed across the first 6 days of the
diary; no diaries with the weekly report were missing the day 7
daily response. The missing days were the same across the three
constructs because the electronic diary required completion of
each item. The difference between the weekly response and the
mean of daily responses was the same for diaries with no missing
days and diaries with one or two missing days for each construct
except feeling upset during breathing problems. For this construct, the
difference was larger for diaries with no missing days by 0.29 (P 
0.014).
Analysis was based on 226 weeks of diary data from 98 pa-
tients, comprising 71 (31%) diaries from cohort R and 155 (69%)
diaries from cohort M (Table 4). The majority of patients com-
pleted the maximum number of diaries for their cohort; two dia-
ries were completed by 32 (82%) rehabilitation patients, and three
diaries were completed by 43 (73%) medicine patients. The
amount of within-person variation for each week of diary data was
calculated as the SD of daily responses for an item within one
diary. The average within-person variation for the item overall se-
verity of breathing problems was 0.58 scale points, for activity limita-
ion due to breathing problems it was 0.65 scale points, and for feeling
upset during breathing problems it was 0.58 scale points. Table 4 lists
he mean and standard error for the weekly response and the
ean of daily responses for each construct.
Table 4 – Diary characteristics.
No. of diaries 226
No. of patients 98
No. of diaries per patient, mean (SD) 2.3 (0.7)
One diary 13 (13%)
Two diaries 42 (43%)
Three diaries 43 (44%)
Severity of breathing problems, mean (SE)
Weekly severity 1.71 (0.13)
Mean of 7 days 1.13 (0.09)
Difference 0.59 (0.08)*
Activity limitation due to breathing problems,
mean (SE)
Weekly severity 2.02 (0.13)
Mean of 7 days 1.53 (0.13)
Difference 0.48 (0.06)*
Feeling upset during breathing problems,
mean (SE)
Weekly severity 1.58 (0.13)
Mean of 7 days 1.01 (0.11)
Difference 0.56 (0.06)*
SE, standard error.
* Difference between weekly severity and mean of 7 days is notzero (P  0.001).
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1. Comparison of the weekly response with descriptors of the
daily diary responses
For each construct, the weekly response was less than the maxi-
mum daily response (the difference ranged from 0.23 to 0.40
and was nonzero; P  0.001) and the weekly response was higher
than the mean of daily responses (the difference ranged from 0.48
to 0.59 and was nonzero; P  0.01) (Table 5). The mean (standard
error) of the difference between the weekly report and the mean of
daily responses was 0.59 (0.08) for overall severity of breathing prob-
lems, 0.48 (0.08) for activity limitation due to breathing problems, and
0.56 (0.06) for feeling upset during breathing problems; the effect sizes
of the difference for each construct were 0.50, 0.34, and 0.46, re-
spectively.
For each construct, the Pearson’s correlation coefficient was
larger for the mean of daily responses than it was for the maxi-
mum; however, the bias correction factor of the maximum was
closer to 1.00 than it was for the mean of daily responses; there-
fore, the CCC, which is the product of Pearson’s correlation coef-
ficient and the bias correction factor, was larger for the maximum
than it was for the mean of daily responses for two of the three
constructs. For the three constructs, the CCC of the mean daily
response ranged from 0.64 to 0.78 and the CCC of the maximum
Table 5 – Comparison of weekly response with descriptors
Sample
Mean SD
Severity of breathing problems
Weekly response 1.71 1.38
Mean 1.13 0.97
Median 1.04 1.03
Mode—max 1.11 1.14
Mode—min 0.95 1.03
Maximum 1.95 1.34
Minimum 0.50 0.80
Day 7 (last day) 1.08 1.17
Day 6 1.09 1.13
Day 1 (first day) 1.27 1.25
Activity limitation due to breathing problems
Weekly response 2.02 1.43
Mean 1.53 1.37
Median 1.48 1.48
Mode—max 1.56 1.59
Mode—min 1.41 1.53
Maximum 2.42 1.57
Minimum 0.81 1.15
Day 7 (last day) 1.45 1.54
Day 6 1.52 1.54
Day 1 (first day) 1.61 1.57
Feeling upset during breathing problems
Weekly response 1.58 1.35
Mean 1.02 1.11
Median 0.94 1.19
Mode—max 0.98 1.26
Mode—min 0.83 1.17
Maximum 1.87 1.59
Minimum 0.42 0.83
Day 7 (last day) 0.95 1.26
Day 6 0.95 1.25
Day 1 (first day) 1.17 1.42
CCC, concordance correlation coefficient.daily response ranged from 0.72 to 0.75. w2. Examine the difference between the weekly response and the
mean of daily diary responses for subgroups defined by patient
characteristics and patterns of diary responses
The difference between the weekly response and the mean of
daily responses for each construct was compared by subgroups of
patient demographics and health status. The difference was
greater for females than for males for the construct activity limita-
tion due to breathing problems (0.60 vs. 0.35; P  0.026), and the dif-
erence was greater for younger patients (age 49–64 years vs. 65
ears) for the construct feeling upset during breathing problems (0.70
s. 0.42; P  0.03). The difference was larger with lower SF-36v2
cute Physical Functioning scores for overall severity of breathing
roblems (low: 1.09, middle: 0.43, high: 0.36; P  0.003). There was
o variation in the difference by education level, SF-36v2 Acute
ental Health score, MRC grade, or years since diagnosis.
The difference between weekly and mean daily responses for
ach construct was also compared by the range, SD, and mean of
aily responses, as well as by the weekly response (Table 6). The
ifference increased with a larger range (P 0.015) and a larger SD
P  0.012) in daily responses only for the construct overall severity
f breathing problems. The difference decreased by the mean of
aily responses for activity limitation due to breathing problems (P 
.015). For each construct, the difference increased with higher
aily response (N = 226 diaries).
Difference Concordance correlation coefficient
Mean SD CCC
(r  b)
Pearson
(r)
Bias factor
(b)
0.59 0.89 0.64 0.77 0.84
0.67 0.96 0.60 0.72 0.83
0.61 0.99 0.62 0.71 0.88
0.76 1.00 0.56 0.70 0.80
0.23 1.00 0.72 0.73 0.98
1.21 1.09 0.34 0.62 0.55
0.63 1.08 0.57 0.65 0.88
0.61 1.04 0.59 0.67 0.88
0.44 1.16 0.58 0.62 0.94
0.48 0.83 0.78 0.83 0.94
0.54 0.93 0.75 0.80 0.94
0.46 0.99 0.75 0.79 0.95
0.61 0.99 0.72 0.78 0.92
0.40 1.00 0.75 0.78 0.96
1.21 0.97 0.50 0.74 0.68
0.57 1.02 0.71 0.77 0.93
0.49 1.13 0.67 0.71 0.95
0.42 1.07 0.72 0.75 0.96
0.56 0.82 0.71 0.80 0.89
0.63 0.85 0.69 0.78 0.88
0.60 0.93 0.68 0.75 0.90
0.75 0.97 0.60 0.71 0.84
0.29 1.01 0.75 0.78 0.97
1.16 1.08 0.35 0.60 0.58
0.63 0.99 0.64 0.71 0.89
0.64 0.98 0.64 0.71 0.89
0.44 1.22 0.58 0.61 0.96of deekly responses (P  0.001).
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472 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 4 6 6 – 4 7 43. Comparison of the ability of the weekly response and the
mean of daily diary responses to detect differences between
known groups
The discriminant ability of the weekly response and the mean of
daily diary responses was compared for subgroups of the SF-36v2
Acute Physical Functioning and Mental Health subscales and MRC
grade. Therefore, discriminant ability was compared in nine in-
stances (three constructs  three patient variables). In each com-
parison, the standard error was consistently smaller for the mean
of daily diary responses than for the weekly response. The abso-
lute value of the t statistic for a nonzero linear trend across sub-
groups was larger for the mean of daily diary responses than for
the weekly response in seven out of the nine comparisons. The
absolute value of the t statistic was smaller for the mean of daily
responses than for the weekly response for overall severity of
breathing problems by SF-36v2 Acute Physical Functioning sub-
groups and for feeling upset during breathing problems by MRC grade.
Nevertheless, in every comparison, the significance of the t statis-
tic was the same.
4. Comparison of the ability of the weekly response and the
mean of daily diary responses to detect change over time
The average change from time 1 to time 2 was estimated for the
weekly response and for the mean of daily responses (Table 7). The
t statistic for a nonzero change between time 1 and time 2 is pre-
sented. For each construct, the absolute value of the t statistic was
larger for the mean of daily responses than it was for the weekly
Table 6 – Difference between weekly and mean daily repor
Difference Severity of breathing
problems
Diaries Mean (SE)
Total 226 0.59 (0.08)
Range of daily responses
0 39 0.26 (0.08)
1 91 0.62 (0.10)
2 62 0.48 (0.11)
3 26 1.17 (0.28)
4 6 0.71 (0.39)
5 2 0.43 (0.20)
6 0 –
t (sig.)* 2.47 (0.015)
SD of daily responses
Per unit change† 226 0.47 (0.18)
t (sig.)* 2.56 (0.012)
Mean of daily responses
Per unit change† 226 0.09 (0.07)
t (sig.)* 1.28 (0.205)
Weekly response
0 (Not at all) 43 0.16 (0.04)
1 76 0.27 (0.05)
2 47 0.80 (0.09)
3 36 0.82 (0.17)
4 13 1.65 (0.22)
5 9 2.78 (0.55)
6 (Extremely) 2 2.50 (0.56)
t (sig.)* 7.59 (0.001)
Note: Each cell reports the mean (SE) of the difference between week
SE, standard error.
* The t statistic is reported from the t test of regression coefficient ind
the alternate hypothesis of nonzero difference is shown.
† Per unit change is the change in difference per unit change in the mresponse; however, the significance of the change was the same.In addition, there was very little difference in the effect sizes of the
weekly response and the mean of daily responses.
Discussion
For each construct, the weekly response was consistently lower
than the maximum daily response by about one-quarter a re-
sponse scale point (P  0.01) and it was higher than the mean of
the daily responses for that diary period by about one-half a re-
sponse scale point (P 0.001). The difference between the mean of
daily responses and the weekly response ranged from 0.34 to 0.50
SDs, which is too large to be considered equivalent. The weekly
response was most concordant with the mean and the maximum
of daily responses. The hypothesis that the weekly response
would be most similar to the maximum and the last daily response
was not confirmed. The concordance of the weekly response and
the mean of daily responses was moderate, ranging from 0.64 to
0.78.
There was very little variation in difference between weekly
response and the mean of daily responses by patient characteris-
tics. The difference was greater for females for the construct activ-
ty limitation due to breathing problems (P  0.026), it was greater for
ounger patients (age 49–64 years vs. 65 years) for the construct
eeling upset due to breathing problems (P  0.03), and it was greater
ith lower SF-36v2 Acute Physical Functioning score for the con-
truct overall severity of breathing problems (P 0.003). There was no
for each construct, by patient response.
Activity limitation due to
breathing problems
Feeling upset during
breathing problems
iaries Mean (SE) Diaries Mean (SE)
226 0.48 (0.06) 226 0.56 (0.06)
22 0.23 (0.13) 59 0.32 (0.08)
98 0.55 (0.07) 68 0.50 (0.10)
66 0.58 (0.11) 61 0.75 (0.12)
28 0.29 (0.24) 22 0.73 (0.20)
10 0.19 (0.28) 9 1.22 (0.27)
2 1.21 (1.17) 6 0.74 (0.23)
0 – 1 3.43 (0.00)
0.22 (0.827) 1.54 (0.126)
226 0.03 (0.14) 226 0.25 (0.15)
0.23 (0.817) 1.65 (0.103)
226 0.13 (0.05) 226 0.02 (0.06)
2.48 (0.015) 0.45 (0.651)
29 0.37 (0.17) 62 0.15 (0.04)
66 0.37 (0.05) 58 0.44 (0.10)
59 0.79 (0.10) 44 0.90 (0.09)
34 0.53 (0.16) 41 1.16 (0.17)
22 0.73 (0.22) 17 1.19 (0.21)
14 0.93 (0.26) 4 0.68 (0.39)
2 1.64 (0.56) 0 –
3.93 (0.001) 7.89 (0.001)
d mean daily report.
ng the variation in the difference by this variable (df 97); P value for
f daily responses.ting
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agnosis.
The difference increased with a larger range (P  0.015) and
arger SD (P  0.012) in daily responses only for the construct
verall severity due to breathing problems. Therefore, there was not
ufficient evidence to confirm the hypothesis that the differ-
nce would be larger in diaries with a larger range of daily re-
ponses. The difference decreased with larger mean of daily
esponses only for the construct activity limitation due to breath-
ng problems (P  0.015). For each construct, the difference be-
ween the weekly response and the mean of daily responses
as larger for higher weekly responses (P  0.001). These find-
ngs suggest that the magnitude of the difference between the
eekly response and the mean of daily responses was primarily
riven by the weekly response itself, and the difference was not
ssociated with patient characteristics, symptom severity, or
ariability of symptoms measured in the daily diary in any con-
istent way.
The discriminant ability of the weekly report and the daily di-
ry was equivalent in this study sample in that the significance of
values was consistent in each comparison. The ability to detect
hange over time was also consistent between the weekly report
nd the daily diary; the significance of P values was the same and
he effect sizes were very similar. All observations at time 1 and
ime 2 were included in the change analysis; therefore, patients
ho were no longer in the study at time 2 contributed an observa-
ion only at time 1. Although loss to follow-up can bias the mea-
urement of change, the weekly report and the mean of daily diary
eports were from the same set of time 1 and time 2 observations,
nd so the loss to follow-up was identical.
One strength of this study was that all weekly and daily diary
esponses were captured via an electronic handheld device that
ecorded the date and time of all responses. This approach
ade it possible to confirm that responses were made within
he correct time frame. Furthermore, the layout and wording of
he questionnaire items in the weekly response were identical
o the corresponding items in the daily diary except for the
ecall period.
This study compared daily diary and weekly reporting, pooling
Table 7 – Difference by change over time.
Mean (SE)
Construct Time 1
(diaries  91)
Severity of breathing problems
Weekly report 2.01 (0.15)
Mean of 7 days 1.38 (0.11)
Difference 0.63 (0.10)
Activity limitation due to breathing problems
Weekly report 2.24 (0.16)
Mean of 7 days 1.82 (0.16)
Difference 0.42 (0.10)
Feeling upset during breathing problems
Weekly report 1.80 (0.15)
Mean of 7 days 1.12 (0.12)
Difference 0.58 (0.08)
Note: Time 1 is the first diary (week 1) from the rehabilitation and med
of the rehabilitation cohort and week 3 diary of the medicine cohort.
SE, standard error.
* The effect size is calculated as Cohen’s d by using pooled SD.
† The t statistic is reported from the t test of regression coefficient in
96); P value for the alternate hypothesis of nonzero difference is show
and weekly reporting, the t statistic with the larger absolute valueata across the medication and rehabilitation treatment cohorts, pecause there was no reason to expect that the treatment type
tself would affect recall beyond the effect of patient characteris-
ics and response patterns. The findings from the analysis of
hange over time in the pooled data were also evident in each
ohort analyzed separately.
To test whether completing the daily diary affected the pa-
ients’ weekly response, a study of weekly and daily diary re-
ponses in patients with type 2 diabetes randomized patients into
wo groups in which one group completed the daily diary and the
eekly report and the other completed only the weekly report. It
as found that the differences in the weekly responses between
roups were very small and not statistically significant [10].
The relationship between these two types of symptom mea-
urement may be different for other patient populations or in
easurement of other types of symptoms and events. Smaller
ifferences between the mean of daily diary reports and 7-day
ecall were found in analyses of data from youth and adults
ith cystic fibrosis and adult with type 2 diabetes [10,11].
We do not know the prevalence in this data of exacerbations
onfirmed by clinicians. An exacerbation would increase the
everity of daily symptoms, and if it started midweek, it would
ncrease the variability of symptom severity in the diary. We
xamined the effect of both the level of symptoms (mean of
aily reports) and the variability (range of daily reports) on re-
all and found that these were not consistent covariates of the
ifference between the average of the daily diary and 7-day
ecall.
In choosing between a daily diary and weekly reporting, one
onsideration is the extra burden on patients of completing a
uestionnaire daily instead of once a week. If the outcome of in-
erest were day-to-day variation or the exact timing of the onset of
respiratory exacerbation, then only the daily diary would be suit-
ble. Nevertheless, to estimate the average experience of a group
f patients during a 7-day period, the results of this study draw
nto question the added value of a daily diary. Although scores
rom 7-day recall were higher than those from the daily diary,
hese two types of measurements were very consistent in detect-
ng differences between known groups and change from one diary
Effect size* t (sig.)†
Time 2
iaries  87)
Change
1.56 (0.14) 0.45 (0.12) 0.32 3.80 (0.001)
1.02 (0.10) 0.35 (0.08) 0.36 4.45 (0.001)
0.54 (0.09)
1.89 (0.15) 0.36 (0.13) 0.25 2.67 (0.009)
1.43 (0.14) 0.39 (0.12) 0.28 3.29 (0.001)
0.46 (0.07)
1.49 (0.15) 0.31 (0.12) 0.22 2.61 (0.011)
0.96 (0.12) 0.26 (0.09) 0.23 2.78 (0.007)
0.54 (0.10)
cohorts. Time 2 is the last diary from each cohort, that is, week 2 diary
iaries are included except medicine cohort week 2 diaries (d  48).
ng the variation in the patient response by this variable (N 97, df
o highlight any differences in discriminant ability between daily diary
old.(d
icine
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